In this way, Valenti et al. [80] showed higher levels of hepatic FOXO1 mRNA and protein expression levels in MASH patients compared to patients with hepatic steatosis and normal patients. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatohepatitis.